Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Leukemia, Promyelocytic, Acute, Date of authorisation: 05/03/2002, Revision: 29, Status: Authorised | Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Leukemia, Promyelocytic, Acute, Date of authorisation: 05/03/2002, Revision: 29, Status: Authorised | | Multisystem Inflammatory Syndrome in Children (MIS-C) | A webinar on Multisystem Inflammatory Syndrome in Children (MIS-C) was jointly organised by the European Centre for Disease Prevention and Control (ECDC) and the European Society of Paediatric Infectious Diseases (ESPID) on 20 January 2022. | | |